Progressive Left Ventricular Remodeling for Predicting Mortality in Children With Dilated Cardiomyopathy: The Pediatric Cardiomyopathy Registry.

"data s1 acknowledgments we thank the participating centers for subject recruitment and follow-up data collection."

"Disclosures Dr Lipshultz is on the medical advisory board of Secretome Therapeutics, which is a paid position. He is also chairman of the medical advisory board of the Children's Cardiomyopathy Foundation, which is an unpaid position."

"Sources of Funding The Pediatric Cardiomyopathy Registry is supported by grants to S.E.L. from the National Heart, Lung, and Blood Institute (HL53392, HL111459, and HL109090) and the Children's Cardiomyopathy Foundation. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the Children's Cardiomyopathy Foundation. There were no industry relationships involved in the presented work."

"Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00005391."